Trial intelligence / Profile preview

Low-dose epinephrine added to intrathecal bupivacaine + fentanyl for hemodynamic stability in lower limb orthopedic surgery

IRCT20210415050976N4Phase 3Completed

Sponsor
Jahrom University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of epinephrine, sponsored by Jahrom University of Medical Sciences. Primary endpoint: Hemodynamic stability during surgery. Started Oct 2021; status: completed.

02

Drugs

epinephrine

Beyond the preview

Go deeper on IRCT20210415050976N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210415050976N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call